Patent holdings for IPC class C07D 267/02

Total number of patents in this class: 31

10-year publication summary

5
2
0
0
2
2
4
3
0
1
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Bristol-myers Squibb Company
4757
5
Rigel Pharmaceuticals, Inc.
505
5
Gilead Sciences, Inc.
2236
2
Theravance Biopharma R&D IP, LLC
360
2
NMD Pharma A/S
50
2
Glaxo Group Limited
4375
1
Novartis AG
10173
1
Amgen Inc.
4440
1
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
779
1
Daya Drug Discoveries, Inc.
7
1
Enanta Pharmaceuticals, Inc.
424
1
Janssen Sciences Ireland UC
153
1
Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
379
1
KemPharm, Inc.
27
1
KYORIN Pharmaceutical Co., Ltd.
157
1
Novira Therapeutics, Inc.
32
1
Shanghai Hansoh Biomedical Co., Ltd.
360
1
Inogent Laboratories Private Limited
6
1
Praxis Precision Medicines, Inc.
235
1
Merck Sharp & Dohme LLC
3737
1
Other owners 0